MRI Imaging of Labeled Human Islets Transplanted Into the Liver
NCT01050166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2021-04-26
Summary
The purpose of the study is to determine whether human islets labeled by iron contrast agents could be imaged using magnetic resonance after transplantation into the liver of Type 1 diabetic recipients.
Conditions
- Type 1 Diabetes Mellitus
Interventions
- OTHER
-
Transplantation of labeled islets
Sponsors & Collaborators
-
Frantisek Saudek
lead OTHER_GOV
Principal Investigators
-
Frantisek Saudek, MD, DrSc · Institute for Clinical and Experimental Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-15
- Primary Completion
- 2012-12-15
- Completion
- 2012-12-31
Countries
- Czechia
Study Locations
More Related Trials
-
Role of the Liver in Glucose Homeostasis Using Metabolic Imaging
NCT04352738 ·Status: COMPLETED
-
Arginine-stimulated Indication of Early Outcome After Islet Transplantation
NCT05540197 ·Status: ENROLLING_BY_INVITATION
-
Effect of Gastric Bypass Surgery on Pancreatic Islet and Incretin Function - Follow-up Study
NCT02161666 ·Status: COMPLETED
-
Allogeneic Transplantation of Expanded Pancreatic Islet Cells
NCT05990530 ·Status: UNKNOWN ·Phase: PHASE2
-
Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia
NCT02337660 ·Status: COMPLETED ·Phase: NA
-
Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
NCT00190502 ·Status: UNKNOWN ·Phase: NA
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
NCT05294822 ·Status: UNKNOWN ·Phase: NA
-
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
NCT00004419 ·Status: COMPLETED ·Phase: NA
-
Immune Biomarkers of Residual Beta-cell Mass in Type 1 Diabetes
NCT01747967 ·Status: COMPLETED ·Phase: NA
-
Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin
NCT01310452 ·Status: UNKNOWN ·Phase: NA
-
Long Term Follow up of Recipients of Functional Islet Allografts
NCT01999374 ·Status: RECRUITING
-
The Use of Islet Organoids in the Treatment of Pancreatic Surgery-related Diabetes
NCT06415643 ·Status: RECRUITING ·Phase: NA
-
Night Hyperglycemia and Fatty Liver in Type 1 Diabetes
NCT05933018 ·Status: UNKNOWN ·Phase: NA
-
[11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes
NCT02967354 ·Status: COMPLETED ·Phase: NA
-
Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes
NCT01157403 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
NCT01916148 ·Status: AVAILABLE
-
PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus
NCT00633763 ·Status: COMPLETED
-
Clinical Study of 18F-Exendin-4 in Insulinoma
NCT07340437 ·Status: COMPLETED
-
GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
NCT01825148 ·Status: COMPLETED
-
Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes
NCT06991829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed
NCT02199470 ·Status: COMPLETED
-
Cardiac Uptake of Metformin, Visualized by Positron Emission Tomography
NCT03122769 ·Status: COMPLETED ·Phase: PHASE1
-
Study on Pancreatic Islets in Patients Undergoing (Partial) Pancreatectomy (PRECISE)
NCT06150690 ·Status: RECRUITING
-
Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
NCT07258394 ·Status: RECRUITING ·Phase: PHASE3